These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 39046595)

  • 21. Performance of VI-RADS in predicting muscle-invasive bladder cancer after transurethral resection: a single center retrospective analysis.
    Chai JL; Roller LA; Liu X; Lan Z; Mossanen M; Silverman SG; Shinagare AB
    Abdom Radiol (NY); 2024 May; 49(5):1593-1602. PubMed ID: 38502214
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiparametric MRI in differentiation between muscle invasive and non-muscle invasive urinary bladder cancer with vesical imaging reporting and data system (VI-RADS) application.
    Makboul M; Farghaly S; Abdelkawi IF
    Br J Radiol; 2019 Dec; 92(1104):20190401. PubMed ID: 31573328
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detecting Muscle Invasion of Bladder Cancer: An Application of Diffusion Kurtosis Imaging Ratio and Vesical Imaging-Reporting and Data System.
    Qin C; Tian Q; Zhou H; Qin Y; Zhou S; Wu Y; Tianjiao E ; Duan S; Li Y; Wang X; Chen Z; Zheng G; Feng F
    J Magn Reson Imaging; 2024 Jul; 60(1):54-64. PubMed ID: 37916908
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The efficacy and reliability of VI-RADS in determining candidates for repeated transurethral resection in patients with high-risk non-muscle invasive bladder cancer.
    Erkoc M; Otunctemur A; Bozkurt M; Can O; Atalay HA; Besiroglu H; Danis E; Degirmentepe RB
    Int J Clin Pract; 2021 Sep; 75(9):e14584. PubMed ID: 34185372
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vesical Imaging Reporting and Data System (VI-RADS): Are the individual MRI sequences equivalent in diagnostic performance of high grade NMIBC and MIBC?
    Gmeiner J; Garstka N; Helbich TH; Shariat SF; Baltzer PA
    Eur J Radiol; 2021 Sep; 142():109829. PubMed ID: 34252867
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prospective assessment of VI-RADS score in multiparametric MRI in bladder cancer: accuracy and the factors affecting the results.
    Oğuz U; Bekçi T; Öğreden E; Aslan S; Duman A; Demirelli E; Şengül D; Tok DS; Çiftçi OÇ; Tosun A
    Diagn Interv Radiol; 2022 Sep; 28(5):396-402. PubMed ID: 35997477
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiparametric Magnetic Resonance Imaging for Bladder Cancer: Development of VI-RADS (Vesical Imaging-Reporting And Data System).
    Panebianco V; Narumi Y; Altun E; Bochner BH; Efstathiou JA; Hafeez S; Huddart R; Kennish S; Lerner S; Montironi R; Muglia VF; Salomon G; Thomas S; Vargas HA; Witjes JA; Takeuchi M; Barentsz J; Catto JWF
    Eur Urol; 2018 Sep; 74(3):294-306. PubMed ID: 29755006
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel pathway to detect muscle-invasive bladder cancer based on integrated clinical features and VI-RADS score on MRI: results of a prospective multicenter study.
    Bicchetti M; Simone G; Giannarini G; Girometti R; Briganti A; Brunocilla E; Cardone G; De Cobelli F; Gaudiano C; Del Giudice F; Flammia S; Leonardo C; Pecoraro M; Schiavina R; Catalano C; Panebianco V
    Radiol Med; 2022 Aug; 127(8):881-890. PubMed ID: 35763251
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biparametric magnetic resonance imaging assessment for detection of muscle-invasive bladder cancer: a systematic review and meta-analysis.
    Ye L; Chen Y; Xu H; Xie H; Yao J; Liu J; Song B
    Eur Radiol; 2022 Sep; 32(9):6480-6492. PubMed ID: 35362750
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic benefit of multiparametric MRI over contrast-enhanced CT in patients with bladder cancer: A single-center 1-year experience.
    Hagen F; Norz V; Thaiss WM; Mair A; Rausch S; Bedke J; Nikolaou K; Stenzl A; Kruck S; Hepp T; Kaufmann S; Estler A
    Eur J Radiol; 2022 Jan; 146():110059. PubMed ID: 34839167
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detecting Muscle Invasion of Bladder Cancer Using a Proposed Magnetic Resonance Imaging Strategy.
    Wang X; Tu N; Sun F; Wen Z; Lan X; Lei Y; Cui E; Lin F
    J Magn Reson Imaging; 2021 Oct; 54(4):1212-1221. PubMed ID: 33998725
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preoperative Prediction of Muscle Invasiveness in Bladder Cancer: The Role of 3D Volumetric Radiomics Using Diffusion-Weighted MRI, the VI-RADS Score, or a Combination of Both.
    Şam Özdemir M; Azamat S; Özdemir H; Keskin ET; Savun M; Şimşek A; Yardımcı AH
    Ann Surg Oncol; 2024 Sep; 31(9):5845-5850. PubMed ID: 39003377
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of staging MRI to re-resection for localised bladder cancer: Narrative review.
    Klempfner H; Anderson P
    BJUI Compass; 2024 Jul; 5(7):651-661. PubMed ID: 39022656
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vesical Imaging-Reporting and Data System use predicting the outcome of neoadjuvant pembrolizumab in muscle-invasive bladder cancer.
    Necchi A; Basile G; Gibb EA; Raggi D; Calareso G; de Padua TC; Patanè D; Crupi E; Mercinelli C; Cigliola A; Tateo V; Giannatempo P; Moschini M; Briganti A; Montorsi F; Messina A; Ross JS; Pavlick D; De Cobelli F; Brembilla G
    BJU Int; 2024 Feb; 133(2):214-222. PubMed ID: 37803523
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison between biparametric and multiparametric MRI in predicting muscle invasion by bladder cancer based on the VI-RADS.
    Noh TI; Shim JS; Kang SG; Sung DJ; Cheon J; Sim KC; Kang SH
    Sci Rep; 2022 Nov; 12(1):20689. PubMed ID: 36450813
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vesical Imaging-Reporting and Data System (VI-RADS) for assessment of response to systemic therapy for bladder cancer: preliminary report.
    Pecoraro M; Del Giudice F; Magliocca F; Simone G; Flammia S; Leonardo C; Messina E; De Berardinis E; Cortesi E; Panebianco V
    Abdom Radiol (NY); 2022 Feb; 47(2):763-770. PubMed ID: 34919160
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnostic performance of the vesical imaging-reporting and data system for detecting muscle-invasive bladder cancer in real clinical settings: Comparison with diagnostic cystoscopy.
    Kufukihara R; Kikuchi E; Shigeta K; Ogihara K; Arita Y; Akita H; Suzuki T; Abe T; Mizuno R; Jinzaki M; Oya M
    Urol Oncol; 2022 Feb; 40(2):61.e1-61.e8. PubMed ID: 34332846
    [TBL] [Abstract][Full Text] [Related]  

  • 38. VI-RADS in bladder cancer: Overview, pearls and pitfalls.
    Lai AL; Law YM
    Eur J Radiol; 2023 Mar; 160():110666. PubMed ID: 36689790
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prospective Validation of Vesical Imaging-Reporting and Data System Using a Next-Generation Magnetic Resonance Imaging Scanner-Is Denoising Deep Learning Reconstruction Useful?
    Taguchi S; Tambo M; Watanabe M; Machida H; Kariyasu T; Fukushima K; Shimizu Y; Okegawa T; Yokoyama K; Fukuhara H
    J Urol; 2021 Mar; 205(3):686-692. PubMed ID: 33021428
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiparametric MRI Evaluation of VI-RADS for Bladder Tumors Located at the Ureteral Orifice.
    Cai Q; Ling J; Kong L; Huang Y; Lin Y; Wen Z; Li M; Guo Y; Wang H
    Radiology; 2022 Sep; 304(3):593-599. PubMed ID: 35670714
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.